Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cell Specific Gene Expression
Diseases of the Liver and Gallbladder
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Marijana Vujkovic1,2,3, David E Kaplan1,4, Jonas Ghouse5,6,7
1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
这项研究确定了与肝硬化和肝癌 (HCC) 相关的新遗传位置,揭示了预测慢性肝病 (CLD) 患者疾病进展和治疗反应的遗传风险得分.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: